Body Weight Does Not Predict for Anti-Xa Levels after Fixed Dose Prophylaxis with Enoxaparin After Orthopedic Surgery - The post-arthroplasty screening study

By Kovacs M.J.   Weir K.   MacKinnon K.   Keeney M.   Brien W.F.   Cruickshank M.K.  

Thrombosis Research, Vol. 91, Iss. 3, 1998-08 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite

Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin

By Mayr A.J.   Dunser M.   Jochberger S.   Fries D.   Klingler A.   Joannidis M.   Hasibeder W.   Schobersberger W.  

Thrombosis Research, Vol. 105, Iss. 3, 2002-02 ,pp. : 201-204

Elsevier

Access to resources Recommend Favorite

Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients

By Zambruni A.   Thalheimer U.   Coppell J.   Riddell A.   Mancuso A.   Leandro G.   Perry D.   Burroughs A. K.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 9, 2004-09 ,pp. : 830-836

Informa Healthcare

Access to resources Recommend Favorite

Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor

By Hara T.   Yokoyama A.   Morishima Y.   Kunitada S.  

Thrombosis Research, Vol. 80, Iss. 1, 1995-10 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

VERY LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-Xa ACTIVITY OF LOW MOLECULAR WEIGHT HEPARIN (ENOXAPARIN)

By Perez-Requejo J.L.   Lucena-Solano O.   Perez-Garcia M.   Santarelli M.T.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite